These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33160841)

  • 1. Regulation of Normal and Malignant Hematopoiesis by FBOX Ubiquitin E3 Ligases.
    Hynes-Smith RW; Wittorf KJ; Buckley SM
    Trends Immunol; 2020 Dec; 41(12):1128-1140. PubMed ID: 33160841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis.
    Wittorf KJ; Weber KK; Swenson SA; Buckley SM
    Exp Hematol; 2022 Oct; 114():33-42.e3. PubMed ID: 35987460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin proteasome system in immune regulation and therapeutics.
    Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
    Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of F-box E3-ubiquitin ligases in plant development and stress responses.
    Saxena H; Negi H; Sharma B
    Plant Cell Rep; 2023 Jul; 42(7):1133-1146. PubMed ID: 37195503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
    Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
    Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights on the function of SCF ubiquitin E3 ligases in the lung.
    Weathington NM; Mallampalli RK
    Cell Signal; 2013 Sep; 25(9):1792-8. PubMed ID: 23680451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assaying proteasomal degradation in a cell-free system in plants.
    García-Cano E; Zaltsman A; Citovsky V
    J Vis Exp; 2014 Mar; (85):. PubMed ID: 24747194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis.
    Heuzé ML; Lamsoul I; Moog-Lutz C; Lutz PG
    Blood Cells Mol Dis; 2008; 40(2):200-10. PubMed ID: 17919948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
    Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
    Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin E3 Ligase FBXO9 Regulates Pluripotency by Targeting DPPA5 for Ubiquitylation and Degradation.
    Swenson SA; Dobish KK; Peters HC; Bea Winship C; Willow Hynes-Smith R; Caplan M; Wittorf KJ; Ghosal G; Buckley SM
    Stem Cells; 2024 Apr; 42(4):317-328. PubMed ID: 38227647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perilous journey: a tour of the ubiquitin-proteasome system.
    Kleiger G; Mayor T
    Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system.
    Buckley SM; Aranda-Orgilles B; Strikoudis A; Apostolou E; Loizou E; Moran-Crusio K; Farnsworth CL; Koller AA; Dasgupta R; Silva JC; Stadtfeld M; Hochedlinger K; Chen EI; Aifantis I
    Cell Stem Cell; 2012 Dec; 11(6):783-98. PubMed ID: 23103054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.
    Marteijn JA; Jansen JH; van der Reijden BA
    Leukemia; 2006 Sep; 20(9):1511-8. PubMed ID: 16926849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E3 ubiquitin ligase on the biological properties of hematopoietic stem cell.
    Zhan Q; Wang J; Zhang H; Zhang L
    J Mol Med (Berl); 2023 May; 101(5):543-556. PubMed ID: 37081103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ubiquitin ligases in neural stem and progenitor cells.
    Naujokat C
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):177-88. PubMed ID: 19479207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulation by protein degradation.
    Koepp DM
    Methods Mol Biol; 2014; 1170():61-73. PubMed ID: 24906309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
    Kitagawa K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic approaches to identify E3 ligase substrates.
    Iconomou M; Saunders DN
    Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the ubiquitin-proteosome system in neurogenesis.
    Tuoc TC; Stoykova A
    Cell Cycle; 2010 Aug; 9(16):3174-80. PubMed ID: 20852390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.